Informations techniques
Exploitant
AOP ORPHAN PHARMACEUTICALS AG
Présentation
ANAGRELIDE AOP 0,5 mg, gélule
B/100 - Code CIP : 34009 301482 2 8
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
UzMJhgVxc6hLQKsT